Invesco Ltd. Lowers Position in MetLife, Inc. (NYSE:MET)

Invesco Ltd. trimmed its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 6,375,197 shares of the financial services provider's stock after selling 711,772 shares during the quarter. Invesco Ltd. owned about 0.92% of MetLife worth $522,001,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Retirement Wealth Solutions LLC acquired a new position in MetLife during the fourth quarter worth about $32,000. Sierra Ocean LLC acquired a new stake in MetLife in the fourth quarter valued at approximately $32,000. Graney & King LLC bought a new stake in shares of MetLife during the fourth quarter worth $34,000. Values First Advisors Inc. acquired a new position in shares of MetLife during the fourth quarter worth $36,000. Finally, Golden State Wealth Management LLC bought a new position in shares of MetLife in the 4th quarter valued at $44,000. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Trading Up 2.5 %

MET traded up $1.81 during trading on Monday, hitting $73.21. The company's stock had a trading volume of 676,006 shares, compared to its average volume of 3,393,577. The firm has a market capitalization of $49.87 billion, a P/E ratio of 12.26, a PEG ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The stock's fifty day moving average price is $80.32 and its 200-day moving average price is $82.46. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on MET. StockNews.com lowered MetLife from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. UBS Group boosted their target price on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a report on Wednesday, April 2nd. Piper Sandler raised their price target on shares of MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Finally, Cowen reiterated a "buy" rating on shares of MetLife in a report on Friday, March 7th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, MetLife presently has a consensus rating of "Moderate Buy" and a consensus target price of $92.46.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.